Cancer News
Prostate cancer screening reduces deaths by 20% in 13-year study
A European study involving over 162,000 men demonstrated the benefits of prostate cancer screenings. However, its leader mentions the risk of over-diagnosis.
Childhood cancer survivors are not always healthier adults
People who have survived cancer as a child do not always lead a healthier lifestyle once they are adults. For instance, they eat less healthy than their peers.
First non-invasive DNA screening test for colorectal cancer approved
The US FDA has approved the first stool-based colorectal screening test that can detect the presence of precancerous or cancerous growths via the blood and DNA.
Multiple myeloma drug approved for re-treatment in the US
The US FDA approved bortezomib for the re-treatment of multiple myeloma adult patients who relapsed at least six months after responding to bortezomib therapy.
Being overweight may be linked with 10 common cancer types
A study of 5 million people showed that larger body size is linked with 10 common cancer types incl. uterine, gallbladder, kidney, cervical, thyroid & leukemia.
Breast cancer recurrence in overweight women reduced by aspirin
New research across 20 years shows that regular use of aspirin can reduce recurrence of hormone-related breast cancer in overweight and obese women by half.
Childhood Acute Lymphoblastic Leukemia (ALL): 2 genes found involved
Scientists discovered mutations in genes that lead to childhood acute lymphoblastic leukemia (ALL), by analyzing DNA samples of patients across disease stages.
Some breast cancer patients may not benefit from 2nd mastectomy
According to a new study, women without a BRCA gene mutation with early stage breast cancer will not gain a survival benefit if they remove the healthy breast.
Combined IV bevacizumab approved for recurrent metastatic cervical cancer
The US FDA has approved bevacizumab for intravenous infusion for treatment of persistent, recurrent or metastatic cervical cancer, combined with other drugs.
Advanced laryngeal cancer patients benefit more from surgery than chemoradiation
Patients with advanced laryngeal cancer appear to have better survival if treated with surgery, compared to non-surgical chemotherapy and radiation therapy.
Lowering gynecologic cancer risk
There are several things women can do to lower their risk of developing certain types of cancer and improve their chances for survival if they do develop one of them, according to the Society of Gynecologic Oncology (SGO).
Women with breast cancer may overestimate secondary risks
Young women with breast cancer often overestimate both their chance of developing cancer in the other breast and how much removal of that breast is likely to protect them, a new U.S. study suggests.
Screening Cuts Colon Cancer Mortality
Colorectal cancer screening -- be it colonoscopy, sigmoidoscopy, or fecal occult-blood testing -- reduced risks of colorectal cancer mortality, researchers reported in two studies.
Swallow therapy combats post-radiotherapy dysphagia
Swallowing exercises can help to minimize the risk for dysphagia in patients undergoing radiotherapy (RT) for head and neck cancer, a case study suggests.
Less is more for radiotherapy in early breast cancers
Giving radiotherapy in fewer, larger treatments is at least as safe and effective at treating early breast cancer as the international standard dose, according to the 10-year follow-up results of a major Cancer Research UK trial, published in The Lancet Oncology.
Integrase Inhibitors Best for HIV Patients With Cancer
For HIV-infected patients with cancer undergoing chemotherapy, the integrase strand-transfer inhibitor raltegravir is the best choice for viral suppression, according to a new study.
Diagnosing early liver cancer with new test
Researchers have found a way to make early liver cancer show its true colors. They have developed a test that will help pathologists clearly distinguish early liver cancer cells from nearly identical normal liver cells by giving them a distinctive red-brown hue.
Patient-reported outcomes provide valuable insight regarding quality of life for patients with non-small cell lung cancer
An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
Some childhood cancer survivors may face subsequent renal problems
Adult survivors of childhood cancers who underwent certain chemotherapy treatments or kidney surgery had worse kidney function that did not recover over time. Because of this, they may be at higher risk for premature renal failure, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Proton Therapy Cuts Side Effects for Pediatric Head, Neck Cancer Patients
The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania. The results were presented Monday at the 55th annual meeting of the American Society for Radiation Oncology (ASTRO) conference.
ASTRO 2013: Long-term hormonal therapy in intermediate-risk prostate cancer patients does not improve overall survival
A secondary analysis of a historic prostate cancer trial examined results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy, and concluded that there were no additional benefits when compared to short-term hormonal therapy, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
Large Retrospective Study Finds Association Between Marriage and Cancer Outcomes
Research shows that cancer patients who were married at the time of diagnosis live markedly longer compared to unmarried ones.
Hyperfractionated radiotherapy improves survival in head and neck cancer patients
The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study to be presented at the 2013 European Cancer Congress (ECC2013).
Longest follow-up of melanoma patients treated with ipilimumab shows some survive up to ten years
Patients with advanced melanoma, who have been treated with the monoclonal antibody, ipilimumab, can survive for up to ten years, according to the largest analysis of overall survival for these patients, presented at the 2013 European Cancer Congress (ECC2013).
ECC 2013: Survival after cancer diagnosis in Europe strongly associated with government health care expenditure
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research presented to the 2013 European Cancer Congress (ECC2013) and published simultaneously in Annals of Oncology.
Roche immunotherapy drug may be 'game changer' in lung cancer
An experimental Roche drug that seems to work particularly well against lung cancer in smokers may be a "game changer" for these normally difficult-to-treat patients, researchers said on Sunday.
Food toxins related to cervical and liver cancer
Food such as corn tortilla, rice, chili pepper, processed sauces, chicken breast and eggs, are related with cervical and liver cancer in humans, according to scientists.
Biological therapy improves survival in women with recurrent ovarian cancer
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented at the 2013 European Cancer Congress (ECC2013).
Merck drug triggers response in 24 percent of lung cancer patients
Early data from a small trial of Merck & Co Inc's experimental immunotherapy cancer drug, known as MK-3475, showed that about a quarter of lung cancer patients responded to the treatment.
After melanoma, people head back to the sun: study
People with the most dangerous type of skin cancer tend to stay out of the sun and wear extra sunscreen the year after being diagnosed. But a new small study suggests those precautions don't last.